A One Health – One World initiative to control antibiotic resistance: A Chile - Sweden collaboration

Abstract

Controlling antibiotic resistance is a global concern. The One Health initiative has provided a strategy to deal with this problem efficiently within a country. However, due to the global nature of the problem it is paramount not only to focus on specific countries, but to establish ways to avoid the development of antibiotic resistance in different geographical regions. In this letter, we propose a One Health - One World approach that would enable different countries to connect by sharing information about infections, outbreaks and surveillance. We believe such a strategy should be implemented worldwide in order to mitigate the development and dissemination of antibiotic resistance.

Anthropogenic Activities and the Problem of Antibiotic Resistance in Latin America: A Water Issue

“…In the veterinary and food production animal sectors, data on therapeutic and prophylactic use of antibiotics are still unavailable [121,122]. Chile, which is one of the countries leading the control of AMR in South America, has not yet established its National Plan to tackle AMR [123]. In summary, antibiotic use and AMR have been low on Latin American governments' policy agendas.…”

The healthcare costs of antimicrobial resistance in Lebanon: a multi-centre prospective cohort study from the payer perspective

“…In recent years, antibiotic resistance became a public health priority and triggered global actions. One Health initiatives [11][12][13] tried to address current related market failures and support measures to mitigate its detrimental worldwide impact [14,15]. With the increased limitations in healthcare resources, expenditures on programs that reduce resistance must efficiently be allocated [2].…”

“…With the increased limitations in healthcare resources, expenditures on programs that reduce resistance must efficiently be allocated [2]. Accurate estimates of the economic burden of antimicrobial resistance (AMR) provide a baseline tool to study the cost-effectiveness of interventions to mitigate this global crisis and gives policymakers the incentives needed to invest in research and funding programs that track and prevent the spread of resistance [10][11][12][13][14][15][16][17][18][19]. Literature review in the field shows that health economics failed so far to demonstrate the real cost of resistance [10][11][12][13][14][15][16][17][18][19][20].…”

“…Accurate estimates of the economic burden of antimicrobial resistance (AMR) provide a baseline tool to study the cost-effectiveness of interventions to mitigate this global crisis and gives policymakers the incentives needed to invest in research and funding programs that track and prevent the spread of resistance [10][11][12][13][14][15][16][17][18][19]. Literature review in the field shows that health economics failed so far to demonstrate the real cost of resistance [10][11][12][13][14][15][16][17][18][19][20]. Published studies quantifying the economic burden of AMR reported a wide variability of cost estimates and showed heterogeneity of methodological assumptions [10,18,[21][22][23][24][25][26][27].…”

The Effectiveness of an Educational Intervention on Knowledge, Attitudes and Reported Practices on Antibiotic Use in Humans and Pigs: A Quasi-Experimental Study in Twelve Villages in Shandong Province, China

“…The emergence and spread of bacterial resistance to antibiotics is a growing problem worldwide [ 1 ]. Over-use and misuse of antibiotics in animals and humans are contributing to the rising problems of resistance, and the “One Health” framework has been recommended by the WHO to govern the intersectoral issue of antibiotic resistance [ 1 , 2 , 3 ]. China is one of the largest consumers of antibiotics globally, over half of which are used on animals [ 4 , 5 ].…”